The Undiagnosed Diseases Program (UDP), an initiative launched by NHGRI, the National Institutes of Health (NIH) Clinical Center and the NIH Office of Rare Disease Research, is celebrating 10 years of tackling the most challenging medical cases. The program kicked off in May 2008 with the mission of offering patients with perplexing conditions the hope of a diagnosis and the therapeutic treatments. Its unique strategy applies advanced genomic medicine technologies and multi-disciplinary medical expertise to unsolved health conditions. Happy 10th Birthday, UDP!
Washington University in St. Louis awarded an honorary Doctor of Science degree to Eric D. Green, M.D., Ph.D., director of NIH's National Human Genome Research Institute, in recognition of his contributions to the field of genomics and its application to medicine. This is the third award given to Dr. Green by Washington University.
Precision medicine will largely be built on vast troves of genomic information, but diverse populations are still underrepresented in public genomic databases, according to a new study by researchers from Partners Healthcare/Harvard Medical School and the National Institutes of Health. They found significantly fewer studies of African, Latin American and Asian ancestral populations compared to European populations in two public databases. Findings were published online May 7 in Health Affairs.
To commemorate the 15th anniversary of the completion of the Human Genome Project, NHGRI celebrated this year's National DNA Day with a Reddit Science "Ask Me Anything" (AMA) Series, sharing genomics expertise to explain the importance of genomics in our everyday lives. NHGRI kicked off the event on Friday, April 20, 2018, with National Institutes of Health (NIH) director, Francis Collins, M.D., Ph.D.
Dan Kastner, M.D., Ph.D., scientific director of NIH's National Human Genome Research Institute, has been selected as a finalist for the 2018 Samuel J. Heyman Service to America Medals ("Sammie's"). He received this honor for identifying a new class of rare genomic diseases and treatments to alleviate suffering for thousands of patients in the United States and around the world. On May 8, the Partnership for Public Service will honor the 27 finalists. Medal recipients will be announced October 2 at a Washington, D.C., gala.